Exelixis Inc
NASDAQ:EXEL
Market Cap (Intraday) | 12.13B |
Current PE | 18.84 |
Forward PE | 16.84 |
2yr Forward PE | 14.16 |
10-Day MA | $44.55 |
50-Day MA | $42.79 |
200-Day MA | $36.49 |
Exelixis Inc Stock, NASDAQ:EXEL
1851 Harbor Bay Parkway, Alameda, California 94502
United States of America
Phone: +1.650.837.7000
Number of Employees: 1147
Description
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.